B
BrainsGate
Innovative medical device enhancing brain blood flow to treat ischemic stroke within 24 hours of symptom onset
About BrainsGate
BrainsGate is a medical device company specializing in the development of a novel treatment modality known as electrical SPG stimulation. This technology is designed to increase blood flow to the brain, offering significant potential for treating central nervous system disorders. The company's primary focus is on improving outcomes for patients suffering from ischemic stroke, particularly within a critical 24-hour window after the onset of symptoms. BrainsGate operates in the healthcare and medical device market, targeting hospitals, clinics, and healthcare providers who treat stroke patients. The business model revolves around the development, clinical testing, and eventual commercialization of its proprietary technology. Revenue is generated through the sale of medical devices and potentially through licensing agreements with healthcare institutions and other medical device companies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2002
- Headquarters
- Hadera, Israel
- Employees
- 19
- Open positions
- None listed
- Dealroom signal
- 40.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Neurology, Neuromodulation and Neurostimulation, Spinout, Tech for Patients, Biotech and Pharma, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES FOther financing | Dec 2020 | $14M | $147M | Cipio Partners · Spero Ventures · Pitango Venture Capital · BNP Paribas | — |
| EARLY VCOther financing | Jan 2015 | $26M | $104M | Elron | — |
Growth signals
Latest recorded traffic for BrainsGate is 70 monthly website visits, down 41.7% over the last three months. BrainsGate's team declined 5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Alice Ventures
Pitango Venture Capital
Series A6 investors entered at this stage
Elron- STShrem, Fudim, Kelner Technologies
Boston Scientific
MB Venture Partners- AIAgate Medical Investments
Johnson & Johnson Development Corporation
Series B and later5 investors entered at this stage
Spero Ventures
Cipio Partners
BNP Paribas
Medtronic
Spero Impact Solutions
Other known investors1 additional known investor
Technion Israel Institute of Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BrainsGate on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BrainsGate’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.